1. Home
  2. BPRN vs IMRX Comparison

BPRN vs IMRX Comparison

Compare BPRN & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Princeton Bancorp Inc. (PA)

BPRN

Princeton Bancorp Inc. (PA)

HOLD

Current Price

$41.17

Market Cap

277.1M

Sector

Finance

ML Signal

HOLD

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$4.23

Market Cap

265.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BPRN
IMRX
Founded
2007
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
277.1M
265.3M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
BPRN
IMRX
Price
$41.17
$4.23
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$17.20
AVG Volume (30 Days)
12.1K
861.2K
Earning Date
04-23-2026
05-04-2026
Dividend Yield
3.93%
N/A
EPS Growth
74.84
37.75
EPS
0.91
N/A
Revenue
N/A
N/A
Revenue This Year
$9.96
N/A
Revenue Next Year
$6.13
N/A
P/E Ratio
$45.65
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.70
$2.90
52 Week High
$43.93
$10.08

Technical Indicators

Market Signals
Indicator
BPRN
IMRX
Relative Strength Index (RSI) 67.33 34.26
Support Level $33.15 $3.95
Resistance Level N/A $5.68
Average True Range (ATR) 1.22 0.25
MACD 0.29 -0.09
Stochastic Oscillator 65.51 1.92

Price Performance

Historical Comparison
BPRN
IMRX

About BPRN Princeton Bancorp Inc. (PA)

Princeton Bancorp Inc is a full-service financial institution providing personal and business banking services, including checking and savings accounts, as well as a range of lending products such as residential, commercial, construction, and consumer loans, including home equity loans and lines of credit. The Bank operates branches and conducts loan origination activities in areas of the New York City metropolitan area. Its loan portfolio is segmented into commercial real estate (including owner-occupied, non-owner-occupied, and multi-family properties), construction loans (mainly for residential developments), commercial and industrial loans (for business purposes), residential real estate loans (secured by one-to-four family properties), and consumer/HELOC loans.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: